New injection may beat standard keloid therapy
NCT ID NCT07201766
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if a drug called bleomycin works better than the usual combination of 5-FU and triamcinolone for shrinking keloids (raised scars). About 104 people aged 13-60 with keloids will receive injections into their scars. Researchers will measure scar improvement over 12 weeks using a standard scar scale.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KELOIDS SCARS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
King Edward Medical University
Lahore, 54000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.